H1N1

A more efficient production process for influenza vaccines could help to cope with future pandemics

A*STAR’s new vaccine, based on a virus-like particle technology created by Cytos Biotechnology AG, could strengthen Singapore’s ability to tackle influenza pandemics

The discovery of distal airway stem cells opens the door to new therapies for reversing pulmonary disease

A silicon-based microfluidic chip that distinguishes different viral strains shows potential for the quick on-site diagnosis of infectious diseases

An innovative system for detecting and identifying the viruses responsible for infectious disease should facilitate decentralized screening of suspect cases

An efficient tool for monitoring the emergence and spread of new H1N1 virus variants has been developed in Singapore